Follow-The-Filings

Security · featured owners

TYRA

Tyra Biosciences Inc. COM Equity among managers we track

  • 1 exit

holders

sorted by % of portfolio · long equity only · exits show last held size · open a manager for their book

history
Farallon Capital Management exited 2026 Q2 last 2026 Q1 0.8% Exit −0.78 pp 3,580,818 $137M hist

0 current · 1 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — — —
Gross profit — — —
Gross margin — — —
Net income -$69.13M -$86.48M -$119.95M
Net margin — — —

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $211.67M $347.46M $265.45M
Total non-current assets * $14.19M $16.1M $17.16M
Total assets $225.86M $363.56M $282.61M
Total current liabilities $15.33M $14.59M $18.09M
Total non-current liabilities * $6.26M $5.81M $5.34M
Total equity $204.26M $343.15M $259.18M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$50.14M -$69.77M -$95.14M
Cash from investing -$144.6M -$98.4M $72.46M
Cash from financing $1.54M $202.14M $8.1M
Net change in cash -$193.21M $33.96M -$14.58M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders